Stocktoria

NRC HEALTH NRC

Nasdaq · stock · Services-Commercial Physical & Biological Research · website · IPO 1997-10-01

NRC HEALTH statistics & valuation

Market cap$469.0M
P / S3.4×
P / B33.5×
P / FCF29.8×
Dividend yield2.34%
FCF margin11.5%
Net debt$70.9M
Net debt / EBITDA2.3×
Enterprise value USD$539.9M
EV / EBITDA17.9×
Earnings yield EBIT/EV4.2%
Return on capital23%
Graham number +27.9%$26.37

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($26.37); a green figure means the price is below it.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
28.50% 29.10% 29.50% 33.60% 32.00% 34.00% 30.70% 27.00% 24.60% 16.40% 2016201720182019202020212022202320242025
Return on equity (%)
24.80% 25.50% 157.50% 2016201720182019202020212022202320242025
Shares outstanding
20.9M 24.8M 25.7M 25.7M 25.6M 25.1M 24.7M 23.7M 22.6M 2016201720182019202020212022202320242025
Net debt ($)
-$29.5M -$33.7M $25.0M $20.8M -$4.0M -$27.7M -$2.7M $30.1M $53.7M $70.9M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
17.00% 18.00% 27.80% 2016201720182019202020212022202320242025
Free cash flow margin (%)
20.90% 20.00% 28.30% 28.30% 27.50% 27.60% 17.40% 15.00% 13.40% 11.50% 2016201720182019202020212022202320242025
Debt / equity (×)
0.04× 0.01× 1.99× 1.04× 0.48× 0.31× 0.31× 0.75× 1.85× 5.36× 2016201720182019202020212022202320242025
EPS ($)
$1.26 $1.45 $1.46 $1.27 $1.25 $1.04 $50.00 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

NRC HEALTH trades at about 0.4× earnings — below its 10-year norm (10-year range 0.4×–53.7×, median 31.2×).

0.4× 53.7×

Shaded band = 10-year range (0.4×–53.7×); dot = today's 0.4×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin16.4%24.6%27.0%30.7%34.0%32.0%33.6%29.5%29.1%28.5%
Net margin———————25.1%19.5%18.8%
FCF margin11.5%13.4%15.0%17.4%27.6%27.5%28.3%28.3%20.0%20.9%
Return on assets———————27.8%18.0%17.0%
Return on equity———————157.5%25.5%24.8%
Debt / equity5.36×1.85×0.75×0.31×0.31×0.48×1.04×1.99×0.01×0.04×
Current ratio0.550.550.671.311.821.710.760.601.621.49

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.